About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Springer Nature
›
top-articles
Springer Nature
533
(top 1%)
papers
12.1K
(top 1%)
citations
56
(top 1%)
h
-index
84
(top 1%)
g
-index
751
all documents
14.3K
doc citations
2.8K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Givosiran: First Approval
Drugs
2020
259
2
BNT162b2 mRNA COVID-19 Vaccine: First Approval
Drugs
2021
232
3
Onasemnogene Abeparvovec: First Global Approval
Drugs
2019
223
4
Tazemetostat: First Approval
Drugs
2020
198
5
Pitolisant: A Review in Narcolepsy with or without Cataplexy
CNS Drugs
2020
193
6
Remdesivir: First Approval
Drugs
2020
176
7
Golodirsen: First Approval
Drugs
2020
174
8
Inclisiran: First Approval
Drugs
2021
172
9
Alpelisib: First Global Approval
Drugs
2019
170
10
Lumasiran: First Approval
Drugs
2021
168
11
Camrelizumab: First Global Approval
Drugs
2019
164
12
Nirmatrelvir Plus Ritonavir: First Approval
Drugs
2022
162
13
The TRUST Principles for digital repositories
Scientific Data
2020
158
14
Sacituzumab Govitecan: First Approval
Drugs
2020
139
15
Pretomanid: First Approval
Drugs
2019
138
16
Casimersen: First Approval
Drugs
2021
136
17
Trastuzumab Deruxtecan: First Approval
Drugs
2020
133
18
The citation advantage of linking publications to research data
PLoS ONE
2020
133
19
Polatuzumab Vedotin: First Global Approval
Drugs
2019
132
20
Pexidartinib: First Approval
Drugs
2019
131
21
Pemigatinib: First Approval
Drugs
2020
131
22
Volanesorsen: First Global Approval
Drugs
2019
123
23
Aducanumab: First Approval
Drugs
2021
118
24
Viltolarsen: First Approval
Drugs
2020
116
25
Sotorasib: First Approval
Drugs
2021
113
26
Dapagliflozin: A Review in Type 2 Diabetes
Drugs
2019
109
27
Entrectinib: First Global Approval
Drugs
2019
104
28
Risdiplam: First Approval
Drugs
2020
104
29
Sodium Oligomannate: First Approval
Drugs
2020
98
30
Erdafitinib: First Global Approval
Drugs
2019
91
31
Setmelanotide: First Approval
Drugs
2021
91
32
Peer review and gender bias: A study on 145 scholarly journals
Science Advances
2021
90
33
A data citation roadmap for scientific publishers
Scientific Data
2018
90
34
Zanubrutinib: First Approval
Drugs
2020
88
35
Selpercatinib: First Approval
Drugs
2020
87
36
Bulevirtide: First Approval
Drugs
2020
86
37
Selinexor: First Global Approval
Drugs
2019
83
38
Belantamab Mafodotin: First Approval
Drugs
2020
83
39
Remimazolam: First Approval
Drugs
2020
82
40
Orelabrutinib: First Approval
Drugs
2021
78
41
Tislelizumab: First Approval
Drugs
2020
76
42
Ozanimod: First Approval
Drugs
2020
73
43
Delgocitinib: First Approval
Drugs
2020
73
44
Avapritinib: First Approval
Drugs
2020
73
45
Nivolumab Plus Relatlimab: First Approval
Drugs
2022
73
46
Upadacitinib: First Approval
Drugs
2019
71
47
Brolucizumab: First Approval
Drugs
2019
70
48
Fedratinib: First Approval
Drugs
2019
69
49
REGN-EB3: First Approval
Drugs
2021
69
50
Selumetinib: First Approval
Drugs
2020
68
site/software ©
exaly
; All materials licenced under
CC by-SA
.